ltrasound-guided infiltration of hyaluronic acid versus corticosteroid for the treatment of morton's neuroma
Not Applicable
- Conditions
- Morton's neuroma in the foot
- Registration Number
- RBR-3gv5cwd
- Lead Sponsor
- Instituto Prevent Senior
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with a clinical diagnosis of Morton's Neuroma confirmed by an ultrasound examination, attended at the outpatients of the group's researchers and signed the informed consent form.
Exclusion Criteria
Patients with neuropathy, skin lesions, previous degenerative injuries to the ankle or previous surgeries on the ankle or Achilles tendon, previous allergy to sodium hyaluronate, allergies to avian proteins, less than 16 years of age, sequelae of tibial pylon fractures, ankle and foot. In addition, patients with collagen disorders, rheumatoid arthritis, seronegative arthritis will be excluded. Patients with previous infiltration will also be excluded.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the study is to compare pain using VAS when applying sodium hyaluronate to Morton's Neuroma compared to using corticosteroids.
- Secondary Outcome Measures
Name Time Method The secondary endpoint of the study is to compare personal satisfaction through the Coughlin score after the application of sodium hyaluronate for Morton's Neuroma compared to the application of corticosteroid.